Interpace Biosciences Inc
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2022
Total Assets: $16.0M
Liabilities Breakdown FY2022
Total Liabilities: $32.5M
Asset Breakdown
Total Assets: $16.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $4.8M | 30.2% |
| Accounts Receivable | $5.0M | 31.5% |
| Inventory | $1.2M | 7.7% |
| Property, Plant & Equipment | $480.0K | 3.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $861.0K | 5.4% |
| Other Assets | $3.6M | 22.2% |
Liabilities Breakdown
Total Liabilities: $32.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.1M | 3.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $31.5M | 96.8% |